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Nuclear factorkB (NF-kB)RelA is the potent transcrip-
tional activator of inflammatory response genes. We
stringently defined a list of direct RelA target genes
by integrating physical (chromatin immunoprecipita-
tion sequencing [ChIP-seq]) and functional (RNA
sequencing [RNA-seq] in knockouts) datasets. We
then dissected each gene’s regulatory strategy by
testing RelA variants in a primary-cell genetic-
complementation assay. All endogenous target genes
require RelA to make DNA-base-specific contacts,
and none are activatable by the DNA binding domain
alone. However, endogenous target genes differ
widely in how they employ the two transactivation do-
mains. Through model-aided analysis of the dynamic
time-course data, we reveal the gene-specific syn-
ergy and redundancy of TA1 and TA2. Given that
post-translational modifications control TA1 activity
and intrinsic affinity for coactivators determines TA2
activity, the differential TA logics suggests context-
dependent versus context-independent control of
endogenous RelA-target genes. Although some in-
flammatory initiators appear to require co-stimulatory
TA1 activation, inflammatory resolvers are a part of
the NF-kB RelA core response.INTRODUCTION
An important concept is molecular biology is the modular
domain organization of transcription factors (TFs) (Keegan
et al., 1986), typically distinguishing between a DNA-binding
domain (DBD) and a separable transcriptional activation domain
(TAD) that could be fused to a heterologous DBD. Prominent2758 Cell Reports 30, 2758–2775, February 25, 2020 ª 2020 The Aut
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(Schmitz and Baeuerle, 1991; Schmitz et al., 1994), conform to
the modular domain model. Such studies used exogenous re-
porter genes that provided a convenient assay for TF activity.
However, they lacked the physiological context of endogenous
regulatory regions, which may involve complex protein-protein
interactions and are often considerable distances from the
transcription start site. Indeed, subsequent studies provided
numerous examples in which the functional distinction between
DNA binding and transcriptional activation did not neatly segre-
gate into distinct structural domains, with the DBD providing
transcriptional activity (Corton et al., 1998) or, conversely, not
being required for TF recruitment to the target gene (Kovesdi
et al., 1986).
Given that the regulatory context of endogenous target genes
determines a TF’s mode of function, next-generation TF struc-
ture-function studies may be considered probes of the regulato-
ry diversity of its endogenous target genes. However, only with
the advent of quantitative transcriptomic and epigenomic mea-
surement capabilities enabled by next-generation sequencing
has it become feasible to undertake such studies. The present
study is leveraging such technological development to dissect
the regulatory strategies of inflammatory response genes that
are regulatory targets of NF-kB RelA.
The NF-kB family member RelA is a ubiquitously expressed
potent transcriptional activator that is induced by exposure to
pathogens and inflammatory cytokines to activate the expres-
sion of many inflammatory and immune-response genes (Hay-
den and Ghosh, 2008; Hoffmann and Baltimore, 2006). The
signaling mechanisms involved in regulating NF-kB RelA activity
have been elucidated in detail (Basak et al., 2012; Mitchell et al.,
2016), but there is much more uncertainty about how it controls
endogenous target genes. Indeed, although many genes have
been identified to be potentially regulated by NF-kB (http://
www.bu.edu/nf-kb/gene-resources/target-genes/), there is no
database that lists the NF-kB target genes in a particular physi-
ological condition, defined cell type, and stimulus.hor(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
RelA’s domain organization is characterized by the Rel homol-
ogy region (RHR), which mediates dimerization and DNA binding
functions (Baeuerle and Baltimore, 1989) and was structurally
characterized by X-ray crystallography (Chen et al., 1998a,
2000). However, it is possible that for some endogenous target
genes, promoter recruitment of RelA is mediated primarily by
protein-protein interactions, for example, via pre-bound CREB-
binding protein (CBP) (Mukherjee et al., 2013).
RelA’s C terminus contains two transactivation domains, TA1
and TA2 (Ballard et al., 1992; Moore et al., 1993; Schmitz and
Baeuerle, 1991), which interact with transcriptional regulatory
factors. TA1 consists of an amphipathic helix characteristic of
an acidic activation domain and can interact withMED80 subunit
of theMediator complex, Tfb1/p62 subunit of TFIIH, and CBP via
the kinase-inducible domain interacting (KIX) domain (van Essen
et al., 2009; Lecoq et al., 2017; Mulero et al., 2019). TA2 also in-
teracts with CBP/p300 but via the TAZ1 domain with sufficient
affinity that it could be characterized by nuclear magnetic reso-
nance (Mukherjee et al., 2013; Nyqvist et al., 2019), as well as
MED80. The RHR was reported to interact with CBP as well via
phosphorylated S276 (Zhong et al., 2002), and knockin muta-
tions of the S276A or S276E mutation showed complex mouse
phenotypes and transcriptional defects (Dong et al., 2008). It
also remains possible that trans-activation of some target genes
is mediated by other sequences within RelA, for example, be-
tween RHR and TA2/TA1.
Interestingly, a key difference between TA1 and TA2 is the role
of post-translational modification (PTM). Unlike TA2, TA1’s
conformation is thought to be regulated (Savaryn et al., 2016)
by phosphorylation of any of seven potential sites (S529,
Ser535, S536, S543, S547, S550, and S551 in human RelA)
altering cofactor interactions (Milanovic et al., 2014) and, hence,
transcriptional activation potential (Hochrainer et al., 2013). In
particular, S536 is a prominent phospho-acceptor site (Christian
et al., 2016), which is a reliable biomarker for RelA activity. This
suggests a model in which TA1’s transactivation activity is
dependent on a phosphorylation event that integrates the activ-
ity of other signaling pathways, such as CKII, CaMKIV, RSK1,
TAK1/TAB1, PI3K/Akt, ATM, and IKKε (Bae et al., 2003;
Bao et al., 2010; Bird et al., 1997; Bohuslav et al., 2004;
Buss et al., 2004a; Haller et al., 2002; Moreno et al., 2010; Saba-
tel et al., 2012; Sakurai et al., 2003; Wang et al., 2000; Yoboua
et al., 2010), whereas TA2’s transactivation potential is intrinsic
to its biochemical structure. Remarkably, however, it remains
unknownwhether NF-kB response genes show differential regu-
lation by TA1 versus TA2; this is an important question because
TA2-regulated genes would be expected to provide for a core
NF-kB-mediated inflammatory response, whereas TA1-regu-
lated genes are dependent on other signaling pathways as well.
Here, we report the stringent identification of endogenous
NF-kB target genes induced by tumor necrosis factor (TNF) in
primary fibroblasts and a genetic complementation system for
RelA variants to probe their regulatory strategies. We found
that all RelA target gene binding was dependent on base-spe-
cific contacts within the kB sequence, and all transactivation
was dependent on the two C-terminal activation domains;
neither the transcriptional activation domain nor did the DNA
binding domain proved sufficient for target gene selection ortranscriptional activation, respectively. However, we discovered
remarkable gene-specific regulatory strategies involving the
transcriptional activation domains TA1 and TA2. Although most
genes were regulated by both TA1 and TA2, the two transactiva-
tions functioned either redundantly or synergistically, forming
logical OR-or-AND gates in a gene-specific manner. Although
OR gate genes were robustly activated by the constitutive TA2
activity, on AND gate genes TA2’s role is to boost the PTM-regu-
lated TA1 activity. Thus, our study distinguishes NF-kB RelA
target genes as being either largely signaling context indepen-
dent or largely signaling context dependent.
RESULTS
Stringent Identification of TNF-Responsive NF-kB RelA
Target Genes
To identify high-confidence NF-kB RelA target genes, we
applied two rigorous criteria, namely (1) TNF-induced NF-kB/
RelA binding to the target gene’s regulatory regions, and (2)
TNF-induced transcriptional activation that is genetically depen-
dent on NF-kB. To examine the genome-wide binding pattern of
NF-kB, we performed chromatin immunoprecipitation followed
by sequencing (ChIP-seq) with RelA-specific antibodies during
a short course of TNF stimulation of 0, 0.5, and 3 h in wild-type
(WT) primarymurine embryonic fibroblasts (MEFs). Bioinformatic
analysis of the replicate datasets (false-discovery rate [FDR] <
0.01) identified in 9,829 RelA peaks that were TNF-inducible at
0.5 or 3 h (Figure 1A). Overall, these ChIP-enriched RelA binding
events were notably enhanced at 0.5 h and largely remained at
3 h (Figure 1B, left panel). We identified the locations of these
RelA peaks to be 44% in intergenic regions, 17% within pro-
moter regions (comprising 5 kb upstream of the transcription
start site), 36% within intronic regions, and 3% within exonic re-
gions of genes (Figure 1B, right panel). Genome browser tracks
of two known NF-kB target genes,Nfkbia andCxcl10, confirmed
easily discernible peaks above a low background, and those
peaks were highly inducible in response to TNF and highly repro-
ducible between the two datasets (Figure 1C).
To assess the NF-kB-dependent transcriptional response to
TNF, we performed gene expression analysis of nascent tran-
scripts via chromatin-associated RNA sequencing (caRNA-
seq) in WT and crel/rela/ MEF cells (Figure 1D). We chose
caRNA-seq analysis rather than polyA+ RNA-seq to ensure that
we identified transcriptional induction, rather than changes in
mRNA levels mediated by post-transcriptional mechanisms,
for example, changes in the mRNA half-life. Previous work has
shown that the absence of RelA can be partially compensated
for by the NF-kB family member cRel (Hoffmann et al., 2003),
necessitating the use of the combination knockout to assess
RelA-dependent gene expression. Our 1-h analysis revealed
419 TNF-inducible genes in WT MEFs whose caRNA levels
were more than 2-fold induced in WT MEFs at any time point af-
ter TNF stimulation relative to the unstimulated (0 h) point (Fig-
ure 1D). Setting the maximum reads per kilobase of transcripts
per million mapped reads (RPKM) for each gene to 1 and the
basal RPKM in unstimulated WT cells to be 0, we plotted data
from crel/rela/ MEF cells next to WT data. We found that
259 genes had peak expression values that were less than halfCell Reports 30, 2758–2775, February 25, 2020 2759
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in the mutant relative to WT, and 160 genes showed expression
that was more than half, leading us to label the former as largely
‘‘NF-kB dependent’’ and the latter largely ‘‘NF-kB independent.’’
Motif-enrichment analysis of the regulatory DNA regions associ-
ated with transcription start sites (TSSs) with HOMER (Heinz
et al., 2010) revealed a preponderance of kB sites in the
NF-kB-dependent genes but no highly significant motif for
NF-kB-independent genes (Figure 1E). Focusing on those that
are protein coding (229 and 120, respectively), we undertook
gene ontology (GO) analysis with Enrichr Ontologies (Kuleshov
et al., 2016) for over-represented functional pathways in each
category. We found that the top five most highly enriched GO
terms (by p value) for the NF-kB-dependent genes described
the inflammatory response and NF-kB activation (Figure 1E),
whereas the NF-kB-independent genes did not yield highly sig-
nificant terms. Line graphs of two NF-kB-dependent genes,
Nfkbia and Cxcl10 (Figure 1F), exemplify the high degree of
NF-kB dependence in their TNF-induced expression.
To develop the list of stringent NF-kB RelA-regulated target
genes, we intersected the above-described physical/binding
data (within 10 kb of each gene’s TSS) and the genetic/functional
data and further ensured that the nascent transcripts were
indeed processed into mature mRNAs by performing polyA+
RNA-seq from total RNA isolated fromWTMEF cells in response
to TNF, extending our time analysis to 3 h (0.5, 1, and 3 h time
points). Selecting for peak fold change in response to TNFs of
R2, an FDR of <0.01 and R50% NF-kB dependence of the
maximum value in the time course, we generated a list of 113
stringently selected NF-kB/RelA-regulated target genes (Fig-
ure 1G). The replicate datasets showed a high level of concor-
dance. The corresponding caRNA-seq data (Figure 1H) indicate
that, aside from the very early gene group, the timing of the peak
mRNA abundance may not be driven by transcriptional mecha-
nisms but, rather, by post-transcriptional mechanisms, such as
mRNA processing (Pandya-Jones et al., 2013) or mRNA half-
life (Hao and Baltimore, 2009). Mapping the RelA ChIP-seq
data associated with each gene (Figure 1I) identified probable
RelA binding events responsible for gene induction but did not
reveal a correlation between RelA binding location and transcrip-
tional induction dynamics.Figure 1. Identifying NF-kB RelA Target Genes in the TNF Response o
(A) Genome-wide binding of NF-kB RelA ChIP-seq in WT MEFs stimulated with 10
independent replicate experiments. The heatmap shows read density along ±0.5
ordered by high to low read density.
(B) Left panel: normalized RelA ChIP-seq density over identified peaks within the g
(C) Genome browser tracks of two replicates (r1 and r2) of RelA ChIP-seq peaks
(D) Heatmap of the relative induced expression of 419 nascent transcripts measur
and R2-fold over basal. Blue to red indicate low to high expression levels, re
dependent, as their maximal expression was <50% in crel/rela/ compared w
dependence.
(E) De novo motif and gene ontology analyses for NF-kB-dependent genes ident
terms (using Enrichr Ontologies tool [Kuleshov et al., 2016]). For NF-kB-indepen
(F) Line plots of chromatin-associated RNA (caRNA) abundance in RPKM for kno
(G) Heatmap of mature mRNA (polyA+ RNA-seq) relative induced expression, as in
ChIP-seq peak and TNF-inducible NF-kB-dependent caRNA expression. Two
expression.
(H) Heatmap of the relative induced expression of nascent transcripts determined
as in (G).
(I) Amap of 297RelA-binding peaks identified byChIP-seq for each of the 113NF-kBAn Experimental System to Dissect Regulatory
Strategies of NF-kB RelA Target Genes
To characterize the regulatory strategies of NF-kB RelA-target
genes by probing them for their requirements of RelA functional
domains, we developed an experimental workflow for retroviral
complementation of RelA-deficient MEF cells with specifically
engineered variants of RelA and performed subsequent tran-
scriptomic analysis in response to TNFs. To prolong the lifespan
of primary MEFs (Todaro and Green, 1963), which would other-
wise not be amenable for such genetic manipulation, we investi-
gated whether we could use MEFs deficient in p53. Transcripts
induced by TNF, interleukin (IL)-1b, or lipopolysaccharide
(LPS), revealed similar gene expression patterns between two
biological replicates of p53-deficient MEFs and their littermate
WT controls (Figure S1A). Pairwise comparisons revealed high
reproducibility in inducible gene expression between p53/
and WT MEFs at each time point (Figures S1B–S1E), justifying
the use of p53-deficient MEFs for studies of inflammatory
response genes.
To develop the primary MEF RelA complementation system,
we bred knockout mouse strains to produce a strain that was
not only deficient in NF-kB subunits but also in p53, which
allowed production of primary p53/crel/rela/ MEF cells
from E12.5 embryos (before embryonic lethality of this genotype
at E13). After expansion of these cells for about a week, we ret-
rovirally transduced them with RelA-wt (Figure 2A), selected
transduced cells with puromycin, and examined complementa-
tion by biochemical assays. Immunoblotting revealed RelA
expression in reconstituted cells at about the same level as WT
control MEFs (Figure S2A). An electrophoretic mobility shift
assay (EMSA) with a kB site probe showed strong DNA binding
activity after TNF stimulation (Figure S2B).
To further test the genetic complementation system, we
examined NF-kB RelA binding via RelA ChIP-seq using RelA-
wt reconstituted MEFs with and without 0.5 h of TNF stimulation
on previously identified endogenous NF-kB target genes (Fig-
ure 1G), such as Nfkbia and Cxcl10 (Figure 2B). Importantly,
we found that RelA-binding peaks identified in WT MEF controls
were indeed also present in the reconstituted RelA-wt cells
(Figure 2C).f Murine Embryonic Fibroblasts (MEFs)
ng/mL of TNF at 0.5 and 3 h; 9,829 RelA-binding events were identified in two
kb of DNA centered around the peak read density for each binding event and
enome. Right panel: pie chart showswhere RelA peaks are found to be located.
in WT MEFs for two known NF-kB target genes, Nfkbia and Cxcl10.
ed by caRNA-seq analysis, whosemaximal induced expression wasR1 RPKM
spectively. Of these 419 genes, 229 genes were protein coding and NF-kB
ith WTMEFs. The heatmap of gene expression is ordered by high to low NF-kB
ified the most highly enriched motif (within 1.0 to 0.3 kb of the TSS) and GO
dent genes, top motifs and GO terms showed substantially less significance.
wn NF-kB target genes, Nfkbia and Cxcl10.
(D), for 113 NF-kB target genes, which were defined by the presence of a RelA
biological replicates of WT MEFs are shown, ordered by their peak time of
by caRNA-seq for these 113 NF-kB-dependent genes shown in the same order
target geneswithin±10 kbof the TSS, shown in the sameorder as in (G) and (H).
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Next, we examined gene expression responses to TNF in re-
constituted MEFs stimulated with TNF using polyA+ RNA-seq.
We found high reproducibility in replicate reconstituted MEFs
on Nfkbia and Cxcl10 (Figure 2D). Extending our analysis to the
113 NF-kB target genes, a scatterplot analysis demonstrated
good correlations in polyA+ RNA expression patterns between
WT MEF controls and the reconstituted RelA-wt MEFs at each
time-point analysis (Figure S2C). Specifically, we found that
104 genes satisfied the same criteria applied to WTs and
crel/rela/ MEFs, namely TNF fold-change over time ofR2,
an FDR of <0.01, and R50% NF-kB dependence of the
maximum expression value in the time-course (Figure 2E),
thereby validating the primary MEF complementation system.
In sum, our analysis revealed 104 NF-kB target genes (Table
S1) that showed robust RelA DNA binding and RelA-dependent,
TNF-inducible expression at both nascent and mature mRNA
transcript level.
All TNF-Induced NF-kB Target Genes Require that RelA
Makes Base-Specific Contacts within the kB Element
Prior structural and functional studies of NF-kB-DNA complexes
demonstrated that NF-kB binds to a variety of kB sites, in which
NF-kB recognizes 9–11-bp palindromic kB DNA elements to the
sequence 50-GGR(N3–5YCC)-30 (Hoffmann et al., 2006). Using
that information, we identified all kB DNA elements that were
associated with all identifiable RelA ChIP-seq peaks (Figure 1I)
for each of the 104 genes (Table S1). Mapping the RelA ChIP-
seq data and kBDNA elements associated with each genewithin
10 kb of their TSSs (Figure 2F), we found kB DNA elements for
223 RelA binding peaks on 104 genes. Those 223 RelA binding
events harbor 617 full-kB and 12,768 half-kB DNA elements
with an FDR of <0.01. When the FDR is relaxed to <0.05, then
the 234 RelA binding events are identified as harboring 663
full-kB and 14,072 half-kB DNA elements, and the conclusions
are confirmed (Figure S2D). Overall, we did not observe a corre-
lation between the relative affinity of the kB site sequence deter-
mined by in vitro protein-binding-DNA microarrays (Siggers
et al., 2011) and the number of reads within a peak (Figure S2E).
To determinewhether DNA-base-specific contacts of the RelA
protein are in fact required for recruiting NF-kB to target sites and
for activating target genes upon inflammatory stimulation,
we generated a triple amino acid mutation (R35A, Y36A, and
E39A), depicted in Figure 3A, termed the RelA DNA-binding
mutant (RelADB). Themutations abrogate base-specific contacts
within the kB sequence (Figure 3B; Chen et al., 1998a). We retro-Figure 2. A RelA Genetic Complementation System for Studying the C
(A) Schematic of the domain structure of the mouse RelA protein (with relevan
experimental assays to be performed.
(B) Genome browser tracks of RelA binding events on the Nfkbia and Cxcl10 gene
from two independent experiments (r1 and r2) are shown.
(C) Heatmap of the read density along ±0.5 kb of RelA ChIP-seq peaks after 0.5
MEFs and p53/crel/rela/ MEFs reconstituted with RelA-wt.
(D) Line plots of mRNA expression in RPKM of Nfkbia and Cxcl10 genes analyze
(E) Heatmap of relative induced expression in reconstituted RelA-wt and empty ve
independent experiments are shown.
(F) A map of the NF-kB binding sites (kB DNA sequences) within each of the 223 R
NF-kB target genes. Full kB elements refer to 9-, 10-, and 11-bp sequences con
N = any nucleotide (A, C, G, or T). Half-kB elements refer to 50-GGR-30 and 50-Yvirally transduced that DNA-binding mutant into primary
p53/crel/rela/ MEFs and examined the NF-kB by
biochemical assays. Immunoblotting confirmed expression of
reconstituted RelADB protein, albeit at slightly lower levels (about
75%) than found with RelA-wt (Figure 3C). Co-immunoprecipita-
tion confirmed that the RelADBmutant was able to associate with
p50 to form dimeric NF-kB and to interact with p105, IkBa, and
IkBb to form higher-order IkB-NF-kB complexes, characteristic
of latent NF-kB in unstimulated cells (Figure S3A). We next as-
sessed the NF-kB DNA-binding activity via EMSA and found
that RelADB showed no kB-site-binding activity in response to
TNF stimulation, unlike the RelA-wt control (Figure 3D), although
immunoblotting of the nuclear extracts confirmed the nuclear
presence (Figure S3B). In sum, the RelADB mutant does not sup-
port high-affinity NF-kB DNA-binding in vitro.
We next examined NF-kB RelA binding in vivo by RelA ChIP-
seq. On previously identified 9,829 endogenous chromatin sites
(Figure 1A), the RelADB mutant showed dramatically diminished
TNF-induced RelA binding (Figure 3E). For example, on Nfkbia
and Cxcl10 genes, TNF-induced RelA binding was dramatically
reduced (Figure S3C). Focusing on the 104 NF-kB target genes
(Figure 2E), we evaluated every previously identified RelA bind-
ing peak and found that most showed a substantial >2-fold
reduction in the RelADB mutant (Figure 3F). Detailed differential
RelA ChIP peak analysis (Table S1) revealed that those few
RelA peaks that were less affected by the RelADB mutant were
generally less prominent in WT cells (Figure 3G), which we inter-
preted to be indicative of the strong contribution of high-affinity
DNA binding ability. Furthermore, they generally showed poorer
kB site motifs, as quantified by in vitro protein-DNA microarray
studies (Figures 3H and S3D). Overall, our analysis reveals that
NF-kB RelA selects most inflammatory-response target genes
via direct RelA-DNA interactions via base-specific contacts.
Next, we investigated whether the reduced kB recruitment of
the DNA binding mutant results in a diminished transcriptional
response from the NF-kB target genes. We performed polyA+
RNA-seq in reconstituted MEFs stimulated with TNF over a 3-h
course analysis (0.5, 1, and 3 h). Examining the model target
genes, Nfkbia and Cxcl10, we found that the RelADB mutant
did not support their gene expression (Figure S3E). Extending
the analysis to the 104 NF-kB target genes, we found that the
TNF-induced gene expression response was almost entirely
abolished in the RelADB mutant cells (Figure 3I). This is also
evident in a principal-component analysis (PCA) of the 104 genes
(Figure S3F), which shows that the transcriptional response ofontrol of Endogenous NF-kB RelA Target Genes
t amino acid numbers) and the primary cells to be complemented and the
s in WTMEFs and p53/crel/rela/MEFs reconstituted with RelA-wt, data
h of TNF treatment for 104 genes identified as NF-kB-dependent genes in WT
d by polyA+ RNA-seq.
ctor (EV) in p53/crel/rela/MEFs, as determined by polyA+ RNA-seq. Two
elA ChIP-seq peaks identified with an FDR < 0.01 and associated with the 104
forming to the consensus: 50-GGR(N3-5)YCC-30, where R = A or G; Y = C or T;
CC-30.
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the mutant largely overlaps with the empty vector control. Only
one gene retained 50% transcriptional activation, Rrad (Ras-
related glycolysis inhibitor and calcium channel regulator). Close
examination revealed some residual RelA binding within the pro-
moter region (Figure S3G), including a kB binding site at123 bp
(50-GGGAATCCCC-30), whose 4G stretch could provide suffi-
cient affinity to heterodimeric NF-kB via the p50 binding partner
(Cheng et al., 2011).
In sum, our analysis showed that for most genes the triple
amino acid mutation abrogates TNF-induced in vivo DNA bind-
ing (RelA ChIP data) and target gene expression. Our results sug-
gest that RelA target-gene selection depends on base-specific
interactions between RelA and the kB site; our data do not rule
out that protein-protein interactions with chromatin-bound fac-
tors contribute to binding-site selectivity but indicate that such
interactions do not suffice for the activation of inflammatory
response NF-kB target genes.
All TNF-Induced NF-kB Target Genes Are Regulated by
Two C-Terminal TA Domains
To investigate the role of RelA’s C-terminal region in the tran-
scriptional activation of endogenous NF-kB target genes, we
first generated two truncated, variant forms of murine RelA: a
full truncation of its C-terminal region (deleting aa 326–549;
D326–549), referred to as C-termD; and a deletion specifically
of its two TA domains (deleting residues 429–549; D429-549),
referred to as TADD (Figure 4A).
Immunoblotting of reconstituted MEFs showed close to WT
expression of the TADD mutant but slightly lower levels of
RelA, IkBa, and IkBb in the C-termD mutant (Figure 4B). Never-
theless, NF-kB DNA-binding activity was detected by EMSA at
comparable levels to that of reconstituted RelA-wt controls (Fig-
ure 4C). Upon stimulation, both mutants showed a normal onset
of TNF-inducible binding activity of NF-kB; however, post-induc-
tion repression characteristic of TNF-induced NF-kBactivity was
abrogated, indicative of defective negative-feedback control.
Indeed, no TNF-inducedNfkbiamRNA expression was observed
in either mutant (Figure 4D).
Extending the analysis to RNA-seq data of the 104 NF-kB
target genes, the PCA plot showed that both mutations resultFigure 3. High-Affinity Binding by RelA Is Required for the TNF-Induce
(A) Schematic representation of the targeted mutations in the DNA binding muta
(B) Schematic of the kB DNA contacts made by RelA:p50 NF-kB heterodimer, ada
contactsmade by specific amino acids in the RelA protein, indicating the critical ro
Van der Waals contacts.
(C) Protein expression of RelA, IkBb, IkBa, and histone 3 as loading control, by im
RelA-wt, and RelADB. Quantified protein expression is shown on the right. Error
(D) Analysis of nuclear NF-kB activity by EMSA with kB and NF-Y (loading control)
genetically complemented cells shown in (C). The data are representative of two
(E) Heatmap density showsRelA ChIP-seq peaks at 9,829 locations defined in Figu
MEFs in response to 0.5 h of TNF stimulation.
(F) A map of RelA binding events associated with 104 NF-kB target genes indica
(G) Quantification and comparison of RelA peaks shown in (F). Averaged norma
RelADB expressing MEFs are plotted to compare RelA peaks that are highly depen
each category, Mann-Whitney U-test results indicate that peaks less dependent o
(H) Correlation between RelA ChIP-seq peaks and protein-binding microarray
RelA:p50 and RelA:RelA dimers retrieved from Siggers et al (2011). Of the seve
strongest z-scores were plotted.
(I) Heatmap for the transcriptional TNF response of the 104 target genes in genetin severe deficiency in TNF-induced gene-expression response
(Figure 4E), largely equivalent to the empty vector (EV) control.
Single-gene analysis by heat-map visualization confirmed that
global picture (Figure 4F): none of the 104 genes showed normal
TNF induction, with only one gene, Slfn2, being induced to about
50% in the TADD mutant. In sum, despite the elevated TNF-
induced NF-kB activity in these mutant cells (because of defi-
cient negative feedback control), the data indicate that all tran-
scriptional activation functions of NF-kB require the C-terminal
activation domains TA1 and TA2.
To determine whether NF-kB target genes have differential re-
quirements for either TA1 or TA2, we constructed variants of
RelA (Figure 5A), a deletion mutant lacking residues 520–549
that define the TA1 (hereafter is referred to as TA1D); a double
amino acid mutant L449A and F473A, which abrogates the
RelA TA2 function of interacting with the TAZ1 domain of tran-
scriptional coactivator, CBP/p300 (Mukherjee et al., 2013),
referred to as (TA2CI); and a double mutant (TA2CITA1D). (Internal
deletion of TA2 appeared to disrupt the function of TA1, which
prompted us to design point mutations within the domain.)
After reconstitution of p53/crel/rela/MEFs, we confirmed
that expression levels of RelA variants and the canonical IkBs
were close to those in RelA-wt control (Figure 5B). Further, gel-
mobility shift analysis confirmed that those targeted mutations
did not interfere with NF-kB dimerization, activation, and DNA
binding to kB sites upon TNF stimulation (Figure 5C). However,
similar to C-termD and TADD mutants examined previously, we
found that NF-kB DNA-binding activity was persistent over the
3-h time, indicative of a loss of proper negative-feedback con-
trol. Indeed, TNF-induced Nfkbia mRNA expression was sub-
stantially diminished in single mutants and abrogated in the
double mutant (Figure 5D).
To extend the gene expression analysis to the 104 NF-kB
target genes, we analyzed RNA-seq data for all described mu-
tants. PCA revealed that both single mutants showed global de-
ficiencies in the TNF-induced gene expression response,
whereas the double mutant appeared almost entirely deficient
in transcriptional activation, akin to the complete TADD mutant
(Figure 5E). Interestingly, visualizing the data at single-gene res-
olution in the heatmap format (Figure 5F) revealed subtled Expression of All NF-kB Target Genes
nt of murine RelA (R35A, Y36A, and E39A).
pted from Chen et al. (1998a). The heterodimer structure reveals base-specific
les of R35, Y36, and E39. Arrows denote hydrogen bonds; brown ovals indicate
munoblot in unstimulated cells genetically complemented with indicated EV,
bars represent the standard deviation from two independent experiments.
probes of nuclear extracts prepared at indicated times after TNF stimulation of
independent experiments. *NS, non-specific band.
re 1A, in genetically complemented (RelA-wt and RelADB) p53/crel/rela/
ting whether RelA binding is reducedR2-fold in the RelADB mutant (red bar).
lized counts from two replicates of RelA ChIP-seq experiments in RelA-wt or
dent on high-affinity binding by RelA versus those that are less dependent. For
n high-affinity binding by RelA show a lower read count in RelA-wt control cells.
(PBM)-determined z-scores of the strongest-kB binding-site sequences for
n 10-bp kB site sequences within not-reduced RelA peaks; the five with the
ically complemented RelA-wt and RelADB cells, analyzed by polyA+ RNA-seq.
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differences in the functionality of the mutants that warranted a
quantitative analysis.
A Model-Aided Analysis Reveals Gene-Specific Logic
Gates Formed by RelA TA1 and TA2
For each RelA target gene to assess the functional requirements
of TA1 and TA2 quantitatively, we had to address the potentially
confounding effect of alterations in the NF-kB activation time
course (Figure 5C). We developed a mathematical formalism
that considered both the measured time courses of mRNA and
the NF-kB DNA-binding activity that drives transcription; hence,
an ordinary differential equation (ODE) model of RelA-dependent
gene expression was constructed (Figure 6A). The model con-
sists of a single ODE representing the rate of change of the
mRNA that resulted from NF-kB-driven synthesis and mRNA
decay (see Method Details). NF-kB-driven mRNA synthesis is a
function of the amount of NF-kB DNA binding activity and the
specific activation activity (kact) of the particular RelA variant.
Given the DNA binding activity measured for each RelA TA
mutant, we could identify the activation rate (kact) for each
gene that optimally accounts for the measured mRNA profile
(Figure 6B). Other parameters (KD; nhill; kdeg) were also fit but
assumed to be the same for all RelA variants because they repre-
sent intrinsic properties of the gene promoter of mRNA. Particle-
swarm optimization was used to minimize the distance between
simulated RNA time courses and the measured RNA-seq data
for each of the 104 genes, and themodel was able to recapitulate
the experimental findings indicating that altered activation
strengths associated with each TA mutant could explain the
altered RNA-seq results (Figure 6C). A stringent criterion
(lnðdistÞ<  2:5, see Method Details) was applied to exclude
28 genes with unsatisfactory fits. For the remaining genes, a
wide range of activation strengths (kact) values were identified
for the TA1D and TA2CI mutants, from 1 (in which TA mutation
did not affect gene induction strength relative to RelA-wt) to
0 (where TA mutation of a single TA domain entirely abrogated
gene expression) (Figure 6C).
Our hope for this analysis was to identify differences in relative
dependence on TA1 versus TA2 among the 104 RelA target
genes, and we found modest specificity: for example, inflamma-
tory genes Cxcl2, Cd83, and Icam1 had greater TA1 depen-
dence, whereas Pdlim4 (Src inhibitor) and Gsap (protease)
showed a higher degree of TA2 dependence. However, for
many genes, the optimally parameterized kact values for TA1
D
and TA2CI mutants were correlated (Figure 6C) with marked dif-
ferences in the degree of the decrease associated with both mu-
tants (Figure 6D). For example, Cxcl1, Cxcl2, and Tnf, showed a
substantial decrease in expression when mutating either TAFigure 4. The RelA C-Terminal Portion Is Required for TNF Induction o
(A) Schematic illustrates the RelA variants to be tested: RelA C-termD (aa 1–325)
(B) Protein expression of RelA, IkBb, IkBa, and actin as loading controls in the in
(C) Analysis of nuclear NF-kB activity by EMSAwith kB andNF-Y (loading control)
of genetically complemented cells shown in (B). The data are representative of t
(D) Line plots of mRNA expression for NF-kB target genes, Nfkbia and Cxcl10, in
(E) PCA plot of all 104 NF-kB target genes in response to TNF in the same cells.
(F) Heatmap of the transcriptional response to TNF of the 104 target genes in th
The data shown in (D), (E), and (F) are averaged RPKM from two independent podomain (Figures 6D and 6E, bottom left), whereas Il15ra and
Il1rl1 expression remained normal when either TA domain was
removed (Figures 6D and 6E, top right). On the former class of
genes, the inability of either TA domain to function effectively
on its own suggests that TA1 and TA2 function synergistically,
whereas, on the latter class of genes, they seem to function
redundantly or independently. Thus, the unexpected conclusion
from this analysis is that RelA target genes differ whether they
impose an AND gate or an OR gate logic on the two TA domains
within RelA. Given that the activity of TA1 is thought to be depen-
dent on the phosphorylation status of serines in its amphipathic
helix, an AND-versus-OR gate logic determines distinct regula-
tory role for TA2: in the latter case, TA2 may be primary driver
of transcriptional activation, but in the former case, TA2 merely
assists or boosts TA1-driven gene activation.
A Knockin Mouse Reveals that Regulatory Strategies of
RelA Target Genes Are Generally Conserved in Different
Cell Types but Are Often Stimulus Specific
The complementation of RelA-deficient primary MEF cells with
mutated variants of RelA allowed us to study the effects of
numerous specific mutations on the TNF response. To dissect
regulatory strategies of endogenous target genes in other cell
types and in response to other stimuli, we engineered a mouse
strain that harbors the previously described RelA TA2CITA1D
variant as a knockin mutation, termed RelATA (Figure S4A).
Homozygous RelATA/TA mice are not embryonically lethal, unlike
the RelA/ mice, but are sickly and smaller than their heterozy-
gous littermates (Figure S4B), whose genotype was verified by
PCR (Figure S4C). To examine whether RelA target genes
showed similar or differential regulatory strategies in other cell
types and other inflammatory stimuli, we produced extensive
RNA-seq data by stimulating WT and RelATA/TA primary MEFs
and bone-marrow-derived macrophages (BMDMs) with TNF or
Toll-like 4 receptor ligand LPS.
We first identified genes that were activated in both MEFs and
BMDMs by a stringent log2 fold-change >2 threshold (Figure 7A).
We found 37 such genes in response to TNF and 481 in response
to LPS stimulation (Figure 7A). After peak-normalizing the data
for each gene, we plotted the relative-expression data from
WT and RelATA/TA MEFs and BMDMs in order of induction
peak time in WT MEFs and subsequent hierarchical clustering
(Figure 7B). We found that most gene-activation events were
diminished in both mutant MEFs and BMDMs. We evaluated
the phenotype by plotting the percentage of expression in
RelATA/TA cells relative to the WT peak expression at the same
time point for each gene (Figure 7C). In MEFs, most genes
were TA dependent (28/37), and most of those (25/28) weref All NF-kB Target Genes
and RelA TADD (aa 1–428).
dicated, unstimulated cells assayed by immunoblotting.
probes of nuclear extracts prepared at the indicated times after TNF stimulation
wo independent experiments.
response to TNF in the same cells.
e same cells. Relative induced expression is shown.
lyA+ RNA-seq experiments.
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Figure 5. RelA Transactivation Domains TA1 and TA2 Both Contribute to the TNF Response of NF-kB Target Genes
(A) The schematic illustrates the RelA variants to be tested: a deletion mutant of TA1, a CBP-interaction mutant of TA2 (TA2CI) and a combination mutant.
(B) Protein expression of RelA and a-tubulin as loading control, in indicated unstimulated cells assayed by immunoblotting with antibodies specific to RelA
and a-Tubulin.
(C) Analysis of nuclear NF-kB activity by EMSAwith kB andNF-Y (loading control) probes of nuclear extracts prepared at the indicated times after TNF stimulation
of genetically complemented cells shown in (B). The data are representative of two independent experiments.
(D) Line plots of mRNA expression for Nfkbia and Cxcl10 genes in response to TNF stimulation in the same cells.
(legend continued on next page)
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also TA dependent in BMDMs. In response to LPS, most genes
were TA independent in both MEFs and BMDMs, given the
strong activation of NF-kB-independent signaling pathways of
IRF3/ISGF3 and MAPK p38. However, of the 154 genes that
were identified as TA dependent in MEFs, 90% showed an
equivalent degree of TA dependence in BMDMs. These data
suggest that regulatory strategies of RelA target genes are
generally conserved in different cell types when induced by the
same stimulus.
We then asked whether regulatory strategies of NF-kB target
genes may be stimulus specific. To that end, we identified 146
genes that were induced by both TNF and LPS in MEFs and
185 that were induced by both stimuli in BMDMs (Figure 7D).
Heatmap visualization of the gene expression time courses re-
vealed that most genes induced rapidly by TNF peaked later in
response to LPS (Figure 7E, left and right panels). Examining
their RelA TA dependence by collapsing the data to the peak
time point, we found that, of the 120 MEF genes that were
TA-dependent in response to TNF, only 60% showed an equiv-
alent degree of TA dependence in response to LPS, and 15%
were entirely TA independent (Figure 7F, left and right panels).
Similarly, of the 26 genes whose TNF induction was TA indepen-
dent, half showed TA dependence in response to LPS. In
BMDMs, the lack of equivalence was even more pronounced:
only 25% showed an equivalent degree of TA dependence (or in-
dependence) in response to TNF and LPS, and more than 40%
showed entirely the opposite regulatory requirements for RelA’s
TA domains.
We also assessed the 104 RelA target genes identified previ-
ously in the primary MEF RelA complementation system that
were expressed in the knockin MEFs and BMDMs in response
to TNF and LPS stimulations (Figure S5A). We found that all of
those genes were induced in MEFs by >2-fold but not all of
them were induced in BMDMs (grayed out rows marked by an
asterisk), indicative of cell-type-specific epigenomes or
enhancer landscapes. In response to TNF, induction of all 104
genes was almost entirely abrogated in the RelATA/TA MEFs
(left panel), whereas in response to LPS, a small subset of genes
remained induced.
We wondered whether compensation by cRel, which was
documented in RelA/ MEFs (Hoffmann et al., 2003), was
affecting our results. We thus bred the RelATA knockin strain to
a crel/ background and produced RNA-seq data from
crel/RelATA/TA and crel/ MEFs in response to TNF and
LPS stimulations. We found that all 104 target genes were
induced by both TNF and LPS in crel/ control MEFs (Fig-
ure S5A). Interestingly, in response to LPS, those genes that
showed induction in the mutant, by and large, also showed
induction in the mutant in the crel/ background. Further, ex-
panding our view to all genes induced by both TNF and LPS
by log2 fold change >2 (and maximum RPKM >1), we found
146 genes in WT MEFs; of which, 145 also satisfied these strin-
gent criteria induced in crel/ MEF controls. Our results with(E) PCA plot of all 104 NF-kB target genes in response to TNF in the same cells.
(F) Heatmap of the transcriptional response of the 104 target genes in the same
The data shown in (D), (E), and (F) are the averaged RPKM from two independent e
TA2CI and TA2CITA1D.crel/RelATA/TA and RelATA/TA MEFs demonstrate that the
lack of RelA TA dependence is generally not due to cRel
compensation (Figure S5C).
The stimulus-dependent requirement of RelA TAs suggested
that gene regulatory strategies are stimulus specific. To investi-
gate whether that could be explained by the induction of distinct
combinations of TFs, we performed motif-enrichment analysis.
We found that regulatory regions of genes that were RelA TA
dependent in response to both TNF and LPS were highly en-
riched for kB sites (Figure S5C, right panel). In contrast, genes
that were TA dependent in the TNF, but not in the LPS, condition,
showed enrichment also of interferon response factor (IRF) and
PU.1:IRF8 binding sites, akin to previously identified the IRF-
NF-kBOR gate genes (Cheng et al., 2017). Further, the 26 genes
that showed RelA TA-independent induction in response to both
TNF and LPS did not show enrichment to any stimulus-induced
TFs. To further examine whether these TA-independent genes
are also NF-kB independent for their transcriptional response,
we looked at their TNF response in p53/crel/rela/ MEFs
reconstituted with empty vectors and found that almost all
showed substantial TNF induction (Figure S5D); whether the
data for two outliers is reliable may require additional experi-
ments, but generally, our results indicate that NF-kB’s capacity
to induce inflammatory-response genes depends on RelA’s
transactivation domain.
In sum, our transcriptomic analysis using newly developedRe-
lATA/TA mice revealed that regulatory strategies of RelA target
genes were generally conserved between MEFs and BMDMs
when the same stimulus was used but that, in either cell type,
RelA TA dependence observed in response to TNF was not
always correlated with dependence in response to LPS, which
also induces IRF family members. These data indicate that
some NF-kB target genes are capable of engaging distinct reg-
ulatory strategies to different stimuli depending on the availability
of stimulus-induced TFs (Cheng et al., 2017, 2015; Ourthiague
et al., 2015).
DISCUSSION
In this study, we reveal gene-specific regulatory strategies of
endogenous RelA target genes in primary cells by probing their
stimulus-induced expression with engineered RelA variants.
We stringently identified target genes by both functional and
physical binding criteria, developed an experimental system to
test mutational variants in primary cells, and systematically
analyzed both chromatin DNA recruitment and transcriptional
trans-activation at single-gene resolution. A key transcriptional
activation domain mutation was produced as a knockin mouse
mutant line to examine other cell types and stimuli, and a math-
ematical modeling approach enabled a quantitative analysis to
reveal gene-specific logic gates formed by the two TA domains.
We first showed that RelA recruitment and transcriptional acti-
vation of all endogenous NF-kB target genes induced by TNF arecells. Relative induced expression is shown.
xperiments of EV, RelA-wt, TADD, and TA1D and 1 polyA+ RNA-seq replicate of
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Figure 6. A Math Model-Aided Analysis Reveals Gene-Specific Requirements for TA1 and TA2
(A) Schematic of the ordinary differential equation (ODE) used to obtain simulated mRNA dynamics from quantified NF-kB activity time courses.
(B) Schematic of the particle swarm optimization (PSO) pipeline used to quantify the activation strengths (kact) for TADmutants. FirstKD; nhill ; kdeg are fit to RelA-wt
data with kact = 1. The identified parameters are then maintained with the new kact fit for each TADmutant to obtain the remaining activation strength (see Method
Details).
(legend continued on next page)
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dependent on DNA base-specific contacts. Akin to previous
X-ray structural analysis of the NF-kB-DNA complex (Chen
et al., 1998b), we observed that some RelA binding events only
contain half sites. Importantly, in our RelADB mutant analysis,
the p50 dimerization partner may still contribute to DNA binding
but that appears to be insufficient. Although the gene-expression
response to TNF is rapid, future studies may address whether
the dependence on DNA base-specific contacts also pertains
to longer-term expression dynamics mediated by NF-kB.
Our studies further indicate that all endogenous target genes
induced by TNF require the C-terminal region of RelA that har-
bors two transactivation domains TA1 and TA2. That is remark-
able given that S276 was reported to play critical roles in recruit-
ing CBP/p300 (Zhong et al., 1998), and knockin mutant mice
harboring the S276A mutation showed striking animal pheno-
types and alterations in the expression of many genes, including
some known NF-kB target genes (Dong et al., 2008). Our anal-
ysis suggests that these mechanisms are insufficient for TNF-
induced NF-kB target gene activation and may support the
notion that the phenotype of S276 mutation may be due to alter-
ations at larger time and epigenetic scales (Cheng et al., 2008).
By further probing target genes for the roles of the two C-ter-
minal activation domains TA1 and TA2, we found remarkable
gene specificity. Target genes did not differ verymuch inwhether
they were more highly regulated by TA1 versus TA2, but they
differed in whether they required either just TA or required both
TAs for gene activation. In other words, some NF-kB target
genes allow TA1 and TA2 to function independently, forming a
logical OR gate, and some NF-kB target genes require the syn-
ergistic function of TA1 and TA2, with the TAs forming a logical
AND gate. These distinct regulatory strategies may be mediated
by distinct mechanistic requirements for the recruitment of mo-
lecular co-activators. For example, genes that exhibit an OR
gate logic, are activated sufficiently by recruiting CBP/p300 via
TA2, but genes exhibiting an AND gate logic need not only recruit
CBP/p300 but also additional co-activators via TA1.
The functionality of TA1 is thought to be regulated by PTMs,
particularly phosphorylation, just as the transactivation potential
of the NF-kB protein cRel is modulated by TNF-induced serine
phosphorylation of S460 and S471 in a gene-specific manner
(Starczynowski et al., 2005). In contrast, TA2 is thought to have
intrinsic transactivation activity via a high-affinity interaction
with CBP/p300. However, within TA2, S467 was also reported
as a potential phosphorylation site (Buss et al., 2004b; Geng
et al., 2009; Mao et al., 2009; Schwabe and Sakurai, 2005). To
investigate whether S467 has a role in the TNF induction of
NF-kB target genes in fibroblasts, we constructed the S467A
variant within full-length RelA, TA1-deleted RelA, or the CBP-(C) Experimental (left, RNA-seq) and simulated best-fit mRNA time-course (middl
shown relative to RelA-wt with brighter colors indicating closer activity to RelA-
mutant (kact = 0). Gray indicating a fit with lnðdistÞ<  2:5 (see Method Details) w
(D) Scatterplot of kact for TA2
CI and TA1D for 76 genes with a good fit in (C). Center c
change from RelA-wt and redundancy with respect to a single mutation, to blue k
synergistically to achieve full gene activation). Border colors represent an off-diag
TA1D (yellow). Gray lines indicate the standard deviation of kact from three repea
(E) Bar graphs of kact (relative to themean RelA-wt kact) for RelA-wt, TA2
CI, TA1D, an
relative positions in (D). Error bars indicate standard deviations of kact from threeinteraction mutant TA2CI (Figure S6A). Gel-mobility shift analysis
showed TA2S467A did not alter the DNA-binding activity of NF-kB
compared with each respective parent construct (Figure S6B; cf.
Figure 5C), and protein expression levels of those RelA variants
and the canonical IkBa and IkBb were normal (Figure S6C). We
then undertook polyA+ RNA-seq analysis, and PCA revealed
only minimal alteration in the TNF-induced gene expression
response with S467A in the WT or TA2CI context (Figure S6D).
Furthermore, in a heatmap with single-gene resolution (Fig-
ure S6E), we observed very little effect by the S467A mutation.
Only chemokines Cxcl1, Cxcl2, and Ccl20, which are rapidly
and highly induced, showed a slight reduction but no enhance-
ment. Our data thus confirm that an intrinsic CBP/p300 interac-
tion affinity (probed with the TA2CI mutation) is the primary mode
of function of the TA2 domain. This contrasts with how TA1’s
functionality is enhanced by phosphorylation events mediated
by coordinated kinases, such as CKII and IKKε (O’Shea and Per-
kins, 2008; Buss et al., 2004a; Wang et al., 2000).
What are the implications of this regulatory distinction of
TA1 versus TA2 for the transcriptional control of NF-kB target
genes, which differ in how they employ TA1 and TA2? Consid-
ering NF-kB target genes that are regulated redundantly by
TA1 OR TA2, we would expect them to respond to all inflam-
matory stimuli that activate the IKK-NF-kB axis because TA2
is effective for its induction, and regulated TA1 activity may
merely provide some modulation. In contrast, NF-kB target
genes that are regulated synergistically by TA1 AND TA2 will
be strongly activated only by those inflammatory stimuli that
also induce the phosphorylation of TA1 serines that potentiate
its acidic activation function and recruit other necessary reg-
ulatory cofactors for the synergistic activation to enhance their
transcription through RelA (Blair et al., 1994; van Essen et al.,
2009). Alternatively, TA1 phosphorylation may be a function of
the microenvironmental context defined, thus rendering the
activation of these gene’s tissue context dependent. We
note, for such genes controlled by an AND gate of TA1 and
TA2, the role of TA2 is effectively to amplify the effect of phos-
phorylation-mediated regulation of TA1 in activity, rendering
them more responsive to these PTMs then if they were regu-
lated by only TA1.
To addresswhy somegenesmay require the synergistic activity
of twoTAs,whereas othersdonot,wefirst analyzed the content of
nucleosome-destabilizing CpG dinucleotides (Ramirez-Carrozzi
et al., 2009) in promoter regions.We found that the top 25% target
genes (11 genes) regulated synergistically by TA1 AND TA2 had a
lower percentage of CG content within ±300 bp from their TSS
than the bottom 25% (Figure S7A), supporting a model in which
a more stable nucleosome is more restrictive to gene activation.e) heatmaps, along with identified kact for TA2
CI (yellow) and TA1D (pink). kact is
wt (no effect of mutation) and white indicating complete loss of activity in the
as not found.
olor represents the effect of either a singlemutation (from green kact = 1with no
act = 0 where either mutation abrogates gene induction and both domains work
onal effect in which a gene shows a specific loss of induction in TA2CI (pink) or
ted runs of optimization pipeline.
d TA2CITA1Dmutants, shown for four example genes arranged to indicate their
repeated runs of optimization pipeline.
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Figure 7. A Knockin Mouse Reveals that the Dual TAD Requirement Pertains to Other Cell Types and Stimuli
(A) Venn diagrams display overlap in induced transcriptional response in MEFs and BMDMs. Induced genes satisfy two criteria: log2 fold-change R2 and
maximum RPKM >1, by polyA+ RNA-seq during a 3-h time-course analysis. In response to TNF, 159 genes are induced in WT MEFs and 310 are induced in WT
BMDMs (left panel). In response to LPS, 939 genes are induced in WT MEFs and 805 induced genes in WT BMDMs (right panel).
(B) Heatmaps of relative expression of the induced genes in WT and RelATA/TA mutant MEFs or BMDMs in response to TNF (left panel) or LPS (right panel). Gene
names and data plotted in heatmaps are listed in Tables S2A and S2B for TNF and LPS, respectively.
(C) RelA-TAD dependence of induced genes: percentage of peak expression in RelATA/TA mutant versusWT. Genes are rearranged by their TAD dependence in TNF
stimulation and further re-arranged in each category by LPS response. Genes induced by TNF in MEFs and BMDMs (left panel). Gene names and data plotted in
heatmap are listed in Table S2C. Genes induced by LPS in MEFs and BMDMs. Gene names and data plotted in heatmap are listed in Table S2D (right panel).
(D) Venn diagrams displays overlap in induced transcriptional response to TNF and LPS. InWTMEFs, 159 genes were induced by TNF and 939 by LPS (left panel).
In WT BMDMs, 310 genes were induced by TNF and 805 were induced by LPS (right panel).
(E) Heatmaps of relative expression of TNF- versus LPS-induced genes in WT and RelATA/TA mutant MEFs (left panel) or BMDMs (right panel). Gene names and
data plotted in the heatmap are listed in Tables S3A and S3B for MEFs and BMDMs, respectively.
(F) NF-kB dependence of induced genes: percentage of peak expression in RelATA/TA mutant versus WT. Genes induced by MEFs by TNF and LPS (left panel).
Gene names and data plotted in heatmap are listed in Table S3C. Genes induced by BMDMs by TNF and LPS (right panel). Gene names and data plotted in
heatmap are listed in Table S3D.(An alternative model is the co-regulatory function of GC-binding
Sp1; Van Essen et al., 2009.) Interestingly, these genes also
showed higher kB motif binding z-scores (Figure S7B), possibly2772 Cell Reports 30, 2758–2775, February 25, 2020leading to longer NF-kB residence times, which may allow both
TA domains to be engaged in sequential activation mechanisms.
Indeed, upon TNF stimulation, those genes showed higher RNA
polymerase II (Pol II) ChIP signals at 0.5 and3h (FigureS7C), indic-
ative of higher levels of transcriptional induction.
Examining the types of genes that are regulated redundantly,
versus synergistically, by TA1 and TA2, we are struck that
many genes that provide for negative regulation of inflammation,
such as Il15ra, IL1rl1, Trim47, Slfn2, or RelB fall into the former
category. For those genes, TA redundancy means that they
constitute an inflammatory core response that includes provi-
sions for inflammatory resolution. In contrast, the latter category
includes genes that are key initiators of an inflammatory
response, such as TNF, Ccl20, Ccl2, andCxcl1. For these genes,
TA synergy means that their expression is activated only in
response to a subset of inflammatory stimuli or when tissue-
environmental context provides for the co-stimulatory signal
that TA1 requires.
The here-described paradigm of NF-kB RelA-responsive
gene expression being either redundantly or synergistically
mediated by TA1 and TA2 should prompt a range of further
studies that extend past work on the signals and pathways
that control TA1 phosphorylation and the molecular mecha-
nisms that determine whether a target gene requires the dual
TA1/TA2 functionality. We may imagine that the involvement
of differential co-activators, mediator complexes, nucleosome
movements, or other complex chromatin interactions or recruit-
ment or release of RNA polymerase may have a role in deter-
mining diverse regulatory logics.
More broadly, the present study suggests that the structure-
function relationship of key TFs provides an informative probe
to dissect the diverse gene regulatory strategies that govern their
dozens and hundreds of target genes. Quantitative datasets pro-
duced by next-generation sequencing allow a focus on endoge-
nous genes that may be effectively, quantitatively evaluated
not only bioinformatically (which evaluates average behavior,
assuming commonalities) but also with gene-specific resolution
by mathematical models of the gene-expression process to
reveal regulatory diversity. Thus, we hope that our study pro-
vides an analysis blueprint for future studies; indeed, advances
of CRISPR/Cas9 technology that enable the engineering of var-
iants into the endogenous gene locus is powering studies of
endogenous gene regulatory circuits at single gene resolution.STAR+METHODS
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Antibodies
Rabbit polyclonal anti-RelA Santa Cruz Biotechnology sc-372; RRID: AB_632037
Goat polyclonal anti-RelA Santa Cruz Biotechnology sc-372G; RRID: AB_632037
Rabbit polyclonal anti-RelA Santa Cruz Biotechnology cat# sc-109; RRID:AB_632039
Rabbit polyclonal anti-IkBa Santa Cruz Biotechnology cat# sc-371; RRID:AB_2235952
Rabbit polyclonal anti-IkBb Santa Cruz Biotechnology cat# sc-945; RRID:AB_631696
Rabbit anti-p50 serum BioBharati LifeScience (BBL),
Kolkata, India
Cat#BB-AB0080
Mouse monoclonal anti-tubulin Santa Cruz Biotechnology cat#sc-5286; RRID:AB_628411
Goat polyclonal anti-Actin Santa Cruz Biotechnology cat# sc-1615; RRID:AB_630835
Rabbit polyclonal anti-Histone 3 Abcam cat# ab1791; RRID:AB_302613
Rabbit monoclonal anti-p84 Abcam cat# ab131268; RRID:AB_11156907
Chemicals, Peptides, and Recombinant Proteins
LPS Sigma, B5:055 cat# L2880
Murine TNF R&D Systems cat# 410-MT
Murine IL-1b R&D Systems cat# 401-ML-CF
L-Glutamine Corning cat# 25-005-CI
Penicillin-Streptomycin Solution Corning cat# 30002CI
b-mercaptoethanol ThermoFisher cat# 21985023
Poly(deoxyinosinic-deoxycytidylic) Sigma-Aldrich cat# P4929
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Polybrene Santa Cruz Biotechnology cat# 134220
Blasticidin InvioGen cat# ant-bl
Puromycin InvioGen cat# ant-pr
PMSF (Phenylmethylsulfonyl fluoride) Sigma-Aldrich cat# P7626
DTT (Dithiothreitol) Fisher Scientific cat# BP172-5
methanol-free Formaldehye solution ThermoFisher Scientific cat# 28908
DSG (disuccinimidyl glutarate) ThermoFisher Scientific cat# 20593
EDTA-free protease inhibitors ThermoFisher Scientific cat# 78439
Proteinase K Sigma-Aldrich cat# P2308
PureLink Rnase A ThermoFisher Scientific cat# 12091-021
TRIzol ThermoFisher Scientific cat# 15596026
Prestained Protein marker BioPioneer cat# P-001M
Critical Commercial Assays
Agilent QuikChange II Site-Directed Mutagenesis Kit Agilent Technologies cat# 200523
RNeasy Mini Kit QIAGEN cat# 74104
Direct-zol RNA Microprep Kit Zymo Research cat# R2060
mRNA-seq Library Kit Kapa Biosystems cat# KK8421
RNA-seq Library Kit With RiboErase Kapa Biosystems cat# KK8483
NEBNEXT Ultra DNA Library Prep Kit for Illumina New England BioLabs cat# E7370L
dsDNA BR assay Kit ThermoFisher Scientific cat# Q32853
dsDNA HS assay Kit ThermoFisher Scientific cat# Q32854
AMPure XP beads Beckman Coulter cat A63881
Dynabeads Protein G ThermoFisher Scientific cat# 1004D
SuperSignal West Pico PLUS Chemiluminescent substrate ThermoFisher Scientific cat# 34578
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SuperSignal West Femto Maximum Sensitivity Substrate ThermoFisher Scientific cat# 34095
Deposited Data
Reference SuperSeries for all sequencing data in this study NCBI Gene Expression Omnibus GEO: GSE132540
Experimental Models: Cell Lines
primary mouse embryonic fibroblasts (MEFs) This study N/A
Platinum-E (Plat-E) cells (Morita et al., 2000) N/A
Experimental Models: Organisms/Strains
Mouse: C57BL/6: All murine embryonic friboblasts This study N/A
Mouse: C57BL/6: WT and RelATA/TA This study N/A
Oligonucleotides
NF-Y EMSA probe (50-GATTTTTTCCTGATTGGTTAAA-30;
50-ACTTTTAACCAATCAGGAAAAA-30)
This Lab and this study N/A
kB EMSA probe (50-GCTACAAGGGACTTTCCGCTGGGG
ACTTTCCAGGGAGG-30)
This Lab and this study N/A
Recombinant DNA
pBABE-puro vector plasmid DNA (Morgenstern and Land, 1990) Morgenstern and Land (Addgene plasmid
# 1764; RRID:Addgene_1764)
Software and Algorithms
Epoch Spectrophotometer System Biotek N/A
Qubit 2.0 fluorometer ThermoFisher Scientific N/A
ImageQuant TL v8.1 GE Healthcate N/A
Image Lab v6.0 Bio-Rad N/A
ImageJ v1.50i NIH, USA N/A
ChemiDoc XRS+ Imaging System Bio-Rad N/A
Amersham Typhoon Scanner GE Healthcare N/A
Mathworks MATLAB MathWorks, Inc. R2014a
ChIPseeker v1.18.0 (Yu et al., 2015) N/A
deepTools2 (Ramı´rez et al., 2016) N/A
HOMER (Heinz et al., 2010) N/A
Enrichr (Chen et al., 2013; Kuleshov
et al., 2016)
N/A
IGV (Integrated Genomics Viewer) (Robinson et al., 2011) N/A
R (v3.6.1) N/A http://www.r-project.org/
Wilcox.test function R program N/A
mean and standard deviation Microsoft Excel N/ALEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to andwill be fulfilled by the LeadContact, Alexander
Hoffmann (ahoffmann@ucla.edu). All plasmids generated in this study are available from the Lead Contact upon request.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
Wild-type andRelA, cRel, p53 gene-deficient C57BL/6miceweremaintained in pathogen-free conditions at theUniversity of California,
Los Angeles. The animal protocol for this study were approved by the Institutional Animal Care and Use Committee and by the Univer-
sity of California, Los Angeles Division of Laboratory Animal Medicine. Targeted Neo deleted RelA transactivation domain knock-in
mutantmicewere generated by ingenious Technology Lab (iTL, https://www.genetargeting.com).Wild-type primaryMEFswere gener-
ated by crossing wild-type to wild-type mice at 8 weeks of age. p53/crel/rela/ primary MEFs were generated by crossing
p53/crel/rela+/ male mouse with p53/crel/rela+/ female mouse at 8 weeks of age. Wild-type or RelATA/TA primary MEFs
were generated by crossing RelATA/+ (heterozygous allele) male mouse with RelATA/+ female mouse at 8 weeks of age.Cell Reports 30, 2758–2775.e1–e6, February 25, 2020 e2
Primary Cell Culture
Wild-type or mutant primary MEFs were generated from E11.5-13.5 embryos of mixed gender and cultured in DMEM supplemented
with 10% bovine calf serum (BCS), 1% penicillin-streptomycin and 1% L-Glutamine. BMDMs were made by isolating 5 3 106 bone
marrow cells from mouse femurs of WT or RelATA/TA C57BL/6 mice following red blood cell lysis and seven-day culturing with 30%
L929-conditioned medium.
Cell Lines
Platinum-E (Plat-E) retroviral packaging cell line, a modified cell line derived from HEK293T (Morita et al., 2000), were cultured in
DMEM with 10% FBS supplemented with 1% penicillin-streptomycin and 1% L-Glutamine, blasticidin (10 mg/mL) and puromycin
(1 mg/mL).
METHOD DETAILS
Construction of mutant RelA plasmids
The pBABE-puro plasmid vector containing RelA was constructed by ligating the polymerase chain reaction (PCR)-amplified coding
region of murine RelA (amino acids 1 to 549) restricted with EcoRI and SalI. Agilent QuikChange II Site-Directed Mutagenesis Kit
(Agilent Technologies) was used for all RelA point mutation and deletion variants. DNA bindingmutant (RelADB) within amino-terminal
were mutated by a triple substitution at residues Arg35, Tyr36, and Glu39 to Ala (R35A, Y36A, R39A). Mutagenesis of the carboxyl-
terminal region for C-termD, TADD, and TA1Dwere performed by displacing residues Pro326, Ala429, and Ser520, respectively, with a
STOP codon sequence. All site-specific mutations were verified by Sanger sequencing analysis and sequencing analyses of the
resulting RelA mutants showed that the targeted sites were the only changes in the DNA sequence.
Genetic complementation of MEFs
For transfection, Plat-E cells were plated on 10-cmplates 16-hr the day before transfection at 50%confluent in DMEMsupplemented
with 10% fetal calf serum, 1% penicillin-streptomycin and 1% L-Glutamine. Cells were transfected using 300 mL of Opti-MEM me-
dium (ThermoFisher Scientific) and polyethylenimine (PEI; 1 mg/mL in 1xPBS pH4.5, Polysciences #23966-2) with 7 mg of retroviral
construct DNA, pBABE-puro EV control or RelA expressing constructs (4:1 ratio of PEI (mL):plasmid DNA (mg)). Transfection complex
(Opti-MEMmedium, PEI reagent, plasmid DNA) were incubated for 20-min at room temperature then added drop-wise to Plat-E cells
for 6 hours. Transfected media was replaced with fresh DMEM media containing 10% fetal calf serum, 1% penicillin-streptomycin
and 1% L-Glutamine. Cells were further incubated for a total of 48-hr post-transfection and prior to collecting viruses. Viruses-con-
taining supernatant were filtered through a 0.45 mm filter and used to infect p53/crel/rela/ MEFs with the addition of 4 mg/mL
Polybrene. 48-hr post-infection of cells with viruses the stably transduced cells were selectedwith 2 mg/mL puromycin for a total of 72
hours. Post selection with puromycin, puromycin-containingmediumwas removed and cells are passaged twice for recovery prior to
being expanded in culture for experiments. pBABE-puro empty vector without the RelA gene fragment was used as a negative con-
trol, to maintain a stable retrovirally transduced RelA knockout cell line, meanwhile pBABE-puro containing full-length RelA (RelA-wt)
was used as a positive RelA cell line control.
Western Blotting
For whole cell extracts, 3 3 106 cells were lysed with RIPA buffer containing 1mM PMSF and 1mM DTT followed by lysing with 1x
SDS-PAGE sample buffer containing 5% b-mercaptoethanol. Protein extracts were separated by SDS-PAGE before transfer to nitro-
cellulose membranes and subjected to western blotting. Nuclear and cytoplasmic extracts were performed with standard methods
as described previously (Hoffmann et al., 2002; Werner et al., 2005). Western blots were probed with antibodies listed in the Key
Resources Table and were visualized using SuperSignal West Femto and West Pico (1:10 mixture) Chemiluminescent reagents to
detect chemiluminescence released by HRP-labeled secondary antibodies. The resulting proteins were visualized by ChemiDoc
XRS+ Imaging Systems (Bio-Rad) and Image Lab (Bio-Rad). Western blots of resulting proteins were quantified using ImageJ soft-
ware (NIH, USA).
Electrophoretic mobility shift assay (EMSA)
EMSAwas carried out with standardmethods as described previously (Hoffmann et al., 2002;Werner et al., 2005). In brief, 2.5 mL total
normalized nuclear extracts were incubated for 15-min with 0.01pmol of P32-labeled 38bp double-stranded oligonucleotide
containing two consensus kB sites (50-GCTACAAGGGACTTTCCGCTGGGGACTTTCCAGGGAGG-30; or with NF-Y loading control
(50-GATTTTTTCCTGATTGGTTAAA-30; 50-ACTTTTAACCAATCAGGAAAAA-30) in binding buffer [10mM Tris-Cl (pH 7.5), 50mM
NaCl, 10% glycerol, 1% NP-40, 1mM EDTA, 0.1mg/mL Poly(deoxyinosinic-deoxycytidylic)], in a final reaction of 6 mL. The reaction
mixtures were run on a non-denaturing 5% acrylamide (30:0.8) gel containing 5% glycerol and 1X TGE buffer [24.8mM Tris, 190 mM
glycine, 1mM EDTA] at 200 V for 2 hours. The gel was visualized by Amersham Typhoon Scanner (GE Healthcare Life Sciences) and
analyzed in ImageQuant TL software, in which the NF-Y loading control gel was used to normalize for loading variability.e3 Cell Reports 30, 2758–2775.e1–e6, February 25, 2020
Immunoprecipitation
Whole cell extracts (WCE) were lysed with RIPA buffer containing 1mM PMSF and 1mM DTT. Anti-RelA antibody (Santa Cruz
Biotechnology, sc-372G) was conjugated to prewashed magnetic protein-G beads (Life Technologies Dynabeads) for 30-min at
room temperature followed by addition unstimulated WCE in RIPA buffer containing 1mMPMSF and 1mMDTT and incubation over-
night (16-hr). The beads were then washed thoroughly with 1X TBS-T buffer and IP samples were eluted with 1X SDS-sample buffer
containing 5% b-mercaptoethanol. Sampleswere resolved on SDS-PAGE andwestern blottingwith antibodies specific for anti-RelA,
anti-IkBa, anti-IkBb, and anti-p50.
RNA isolation and sequencing (RNA-seq)
MEF cells at 80% confluence were serum-starved by overnight incubation in Dulbecco’s Modified Eagle’s Medium supplemented
with 0.5% bovine calf serum (BCS), 1% penicillin-streptomycin and 1% L-Glutamine prior to stimulation. For chromatin-associated
RNA-seq (caRNA-seq), nascent RNA transcripts were prepared from the chromatin fraction (Tong et al., 2016) using TRIzol according
to the manufacturer’s instruction (ThermoFisher Scientific) and purified using Direct-zol RNA Microprep Kit (Zymo Research
cat#R2060). RNA libraries were prepared from ribo-depleted using KAPA Stranded RNA-Seq Kit with RiboErase (KAPA Biosystems,
cat#KK8483) with 400ng of starting total RNA material. For polyA+RNA-seq analysis, total RNA was isolated with the QIAGEN
RNeasy Mini Kit according to the manufacturer’s instructions, quantified using Epoch Spectrophotometer System (Biotek), and pu-
rified from 1 mg of starting total RNA material using oligo (dT) magnetic beads before fragmenting at high temperature with divalent
cations. Complementary DNA libraries were generated using KAPA Stranded mRNA-Seq Kit (KAPA Biosystems, cat#KK8421), and
quantitation was performed using Qubit 2.0 fluorometer using dsDNA BR assay kit #Q32853. Sequencing was performed on Illumina
HiSeq 2000 and HiSeq 4000 with single-end 50-bp sequencing, according to manufacturer’s recommendations and prepared by
Broad Stem Cell Research Center core facility at the University of California, Los Angeles.
RNA-seq data analysis
Reads were aligned with STAR to Gencodemousemm10 genome and RefSeq genes and featureCounts were used to obtain aligned
raw counts. Only uniquely mapped reads with a mapping quality score ofR 20 were kept for further analysis, using samtools. Read
counts were normalized for library size and transcript length by conversion to RPKM and gene below the maximum RPKM < 1 were
excluded from downstream analysis. DESeq2 was used identify induced genes for subsequent analysis using the following criteria:
R 2-fold increase in expression at any one time point over basal with FDR threshold of 0.01. Principal components were calculated
with prcomp package and plotted with ggplot. caRNA-seq and polyA+RNA-seq heatmaps were plotted using pheatmap package.
HOMER (Heinz et al., 2010) was used to assess for enrichment of de novo and known transcription factor binding motifs for NFkB
dependent geneswith promoter sequences 1 kb upstream and 0.3 kb downstreamof the transcription start site. An in-depth descrip-
tion of this software can be found at homer.ucsd/edu/homer. Gene ontology analysis in biological processes for NFkB target genes
were performed using Enrichr (Chen et al., 2013; Kuleshov et al., 2016). The 5 most enriched GO terms were selected for NFkB-
dependent genes.
Chromatin immunoprecipitation and sequencing (ChIP-seq)
MEF cells (83 106 cells per plate) were serum-starved overnight with 0.5%BCSmedium, then stimulated with 10ng/mL TNF at indi-
cated time points. For ChIP, cells were double cross-linked with 100mM disuccinimidyl glutarate/PBS solution (DSG, ThermoFisher
Scientific #20593) for 30-min followed by 1%methanol-free Formaldehye/PBS solution (ThermoFisher Scientific #28908) for 15-min.
Cross-linked cells were quenched with 125mMGlycine for 5 min and washed twicewith cold PBS followed by snap freezing with dry
ice. The cell pellets were thawed and lysed in Lysis Buffer 1, on ice. Cells were briefly sonicated with Diagenode Bioruptor 300 son-
ication system (medium power, 15 s ON/15 s OFF, 2 cycles) in Diagenode 1.5mL TPX microtubes (100 ml-max 300 ml/tube). After
centrifugation, cell pellets were lysed in Lysis Buffer 2 and incubated for 10 min at room temperature. Following centrifugation,
cell nuclear pellets were lysed in Lysis Buffer 3. Nuclear lysates were sonicated with Diagenode Bioruptor 300 sonication system
(low power, 30 s ON/30 s OFF, 12 cycles) in Diagenode 1.5mL TPXmicrotubes. Sonication was stopped every 4 cycles for incubation
on ice for 1 min, gentle inversion and pulse-spin. Sonicated nuclear supernatant containing DNA fragments were consolidated with
the same sample into a single 1.5 mL polypropelene tube. The lysates were centrifuged at max speed for 10 min at 4C. The super-
natants were transferred to 2 mL no-stick microtubes (Phenix Research cat# MH-820S) with 3 volumes of Dilution buffer and 5 mg
anti-RelA antibody (Santa Cruz Biotechnology, sc-372), incubated overnight at 4C. Next day, antibody-chromatin complexes
were incubated with 30 mL magnetic protein G beads (Life Technologies Dynabeads protein G #1004D) for 5 hours at 4C. Chro-
matin-immunoprecipitates were washed 3 times (4 min wash at 4C) with each of the following buffer in this order: low-salt wash
buffer, high-salt wash buffer, LiCl buffer, and TE buffer. ChIP DNA was eluted in elution buffer overnight at 65C. 1% inputs and
ChIP DNA fragments were subjected to reverse cross-linking, RNase A digestion (50 mg), Proteinase K digestion (50 mg), and puri-
fication with AMPure XP beads (Beckman Coulter). Input DNA samples were quantified with dsDNA BR assay kit #Q32853, and
ChIP DNA samples were quantified with dsDNA HS assay kit (Q32854). Quantitation was performed using Qubit 2.0 fluorometer.
ChIP-Seq DNA libraries were prepared from 5ng of Inputs or ChIP DNA using NEBNext Ultra DNA Library Prep Kit for Illumina
(New England BioLabs, # E7370L).Cell Reports 30, 2758–2775.e1–e6, February 25, 2020 e4
ChIP Buffer composition
Lysis Buffer 1: 50mM HEPES-KOH (pH 7.6), 140mM NaCl, 1mM EDTA, 10% Glyercol, 0.5% NP-40, 0.25% Triton X-100 [with
freshly added 1X EDTA-free protease inhibitors].
Lysis Buffer 2: 10mM Tris-Cl (pH 8.0), 200mM NaCl, 1mM EDTA, 0.5mM EGTA [with freshly added 1X EDTA-free protease inhib-
itors].
Lysis Buffer 3: 10mMTris-Hcl (pH 8.0), 100mMNaCl, 1mMEDTA, 0.5mMEGTA, 0.1%NaDeoxycholate, 0.5%N-lauroylsarcosine
sodium salt, 0.2% SDS [with freshly added 1X EDTA-free protease inhibitors].
Dilution Buffer: 10mM Tris-Cl (pH 8.0), 160mM NaCl, 1mM EDTA, 0.01% SDS, 1.2% Triton X-100 [with freshly added 1X EDTA-
free protease inhibitors].
Low Salt Wash Buffer: 50mM HEPES-KOH (pH 7.6), 140mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1% Na Deoxycholate, 0.1%
SDS [with freshly added 0.5X EDTA-free protease inhibitors].
High Salt Wash Buffer: 50mM HEPES-KOH (pH 7.6), 500mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1% Na Deoxycholate, 0.1%
SDS [with freshly added 0.5X EDTA-free protease inhibitors].
LiCl Buffer: 20mM Tris-HCl (pH 8.0), 250mM LiCl, 1mM EDTA, 0.5% Na Deoxycholate, 0.5% NP-40
TE Buffer: 10mM Tris-HCl (pH 8.0), 1mM EDTA
Elution Buffer: 10mM Tris-HCl (pH 8.0), 1mM EDTA, 1% SDS
ChIP-seq data analysis
Sequencing reads were aligned to the mouse mm10 genome and RefSeq genes using Bowtie 2 (Langmead and Salzberg, 2012) and
filtered using Samtools. Uniquely mapped reads were used to identify peaks for each sample individually with MACS2 version 2.1.0
using default settings except for FDR of 0.01. Differential RelA binding events were plotted as heatmap using plotHeatmap from
deepTools2 (Ramı´rez et al., 2016). ChIP-seq peak annotation for genomic locations were plotted as pie chart using ChIPseeker
(Yu et al., 2015). For mapping of kB elements to NFkB target genes, any TNF-inducible RelA ChIP-seq peaks within ± 10kb from
gene TSS were annotated to kB elements (unique half and full kB DNA sequences were annotated within the mm10 genome) and
were mapped to each RelA ChIP-seq peak centered at 500bp window (±250bp from each peak of kB sequence) on every gene using
Bedtools intersect. Full-length kBelements were defined by the consensus sequence 50GGRNNNNNYCC-30 for unique 9, 10, or 11bp
DNA sequence; where R is a A or G, Y is a T or C, and N is any nucleotide. kB half sites were defined by the consensus sequence
50GGR or YCC-30 DNA sequence. kB motifs were extracted from UCSC mm10 genome using Biostrings and BSgenome packages.
Mapping of kB motifs and RelA ChIP-seq peaks were visualized by ggplot2 geom_segment. Scatterplots and boxplots of RelA
ChIP-seq data were visualized by ggplot. Wilcox.test function in R was used to find the statistical significance of reduced versus
non-reduced RelA peaks (Mann-Whitney U-test). Integrative Genomics Viewer (IGV) was used to acquire RelA ChIP-seq tracks
for example genes (Robinson et al., 2011).
GC content analysis
GC sequence information was obtained from UCSC annotation for mouse mm10 genome using getSeq package in R with Granges
objects. GC sequences are analyzed for ± 300 bp from each gene TSS. Percentage of GC were plotted as bar graphs using ggplot2
(v3.2.1) with Tidyverse. Wilcox.test function in R (Mann-Whitney U-test) was used to find the statistical significance of GC content.
Computational Modeling
An ODE model was constructed representing the rate of change of mRNA for each gene.
dRNA
dt
=
kact$RelA
n
t
KnD +RelA
n
t
 kdeg$RelA
kact is the mRNA synthesis rate that depends on the activation strength of RelA. KD is the dissociation constant which quantifies the
nuclear abundance of RelA activity that achieves half-maximal gene induction. kdeg is the degradation rate of themRNA that relates to
the half-life with the identity t1/2 = ln(2)/ kdeg. nhill is the Hill coefficient that describes ultra-sensitivity in gene activation, potentially the
result of the cooperative effect of multiple kB sites, or multiple-sequential mechanistic steps that are not explicitly represented in this
model (e.g., NFkBbinding, recruitment of PIC components, promoter opening, initiation, RNA Pol II CTD phosphorylation, etc. RelA is
a time-dependent variable obtained by quantifying RelA DNA-binding activity from EMSA and linearly interpolating between discrete
time points. Basal mRNA for a given parameter set was obtained by analytically solving the ODE with RelA fixed at the basal value:
RNA0 =
kact$RelA
n
0
kdeg$

KnD +RelA
n
0

Induced time-course response was obtained using ode23s in MATLAB (The MathWorks, Inc.). The distance between experimental
and modeled mRNA time courses was quantified using a combination of Pearson correlation and MSE to take into account both dy-
namics and absolute values (dist = ð1  PearsonÞ + MSE). As KD;nhill; kdeg are assumed to be gene-specific properties, unaffected
by TADmutations these were first fit to WT (RelA-wt) data using particle swarm optimization (PSO) to minimize the distance betweene5 Cell Reports 30, 2758–2775.e1–e6, February 25, 2020
modeled mRNA time-course andmeasured RNA-seq (50 particles, terminating at either 100 epochs or distance below 0.001). As the
RNA-seq time-course did not capture a decrease in mRNA levels for late-induced genes, kdeg could not be fit but was assumed to be
equivalent to an 8 hour half-life. Following the fit to the WT data KD; nhill; kdeg were fixed for data frommutant cells and a new kact was
obtained for each TAD mutation using the same optimization approach.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses were carried out using Excel or R (version 3.6.1). Where applicable, statistical significance are reported in the
Figures and corresponding Figure Legends. Western blotting were quantified using ImageJ software and data are presented as
mean + SD. All comparisons in sequencing data were analyzed using Wilcox.test function in R (Mann-Whitney U-test).
DATA AND CODE AVAILABILITY
All sequencing data presented in this publication have been deposited to the NCBI Gene Expression Omnibus (GEO) and accessible
under SuperSeries accession number GSE132540, https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE132540. All quanti-
fied RelA DNA-binding activity as RelA concentration for the model and all values for model parameters for each 3 replicate model
runs are presented in Table S5.Cell Reports 30, 2758–2775.e1–e6, February 25, 2020 e6
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Figure S1. p53 deficiency does not affect TNF-induced gene expression, Related to Figure 
2. (A) Heatmap visualization of upregulated genes in response to IL-1b (10ng/mL), TNF 
(10ng/mL), or LPS (100ng/mL) stimulations at indicated times in WT or p53-/- MEFs. Green to red 
indicates low to high expression levels, respectively. One biological replicate of WT and two 
biological replicates of p53-/- MEFs are shown.  Genes with  ³100 normalized counts in at least 
one condition and an induction  ³4 were sorted into five groups via K-means clustering. (B) 
Scatterplots between significantly upregulated genes in all genotypes at all time points of IL-1β 
stimulation are plotted, with number of genes and R2 value indicated.  Rows are 0.5, 1, 3 and 8hr 
respectively. Columns are p53-/--2 vs. p53-/--1, p53-/--1 vs. WT, and p53-/--2 vs. WT, respectively.  
We restricted our analysis to genes that were upregulated by at least 2-fold in one of the two 
conditions compared. (C) Scatterplots between significantly upregulated genes in all genotypes 
at all time points of LPS stimulations are plotted, with number of genes and R2 value indicated. 
(D) Scatterplots between significantly upregulated genes in all genotypes at all time points of TNF 
stimulations are plotted, with number of genes and R2 value indicated. (E) Summary of 
correlations between different stimuli conditions where bar plots of the R2 values from panels B-
D are shown. 
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Figure S2
Figure S2.  Retroviral transduction of RelA in p53-/-crel-/-rela-/- MEF provides a suitable 
complementation system for studying NFkB RelA target genes, Related to Figure 2. (A) 
Western blotting of RelA levels and a-Tubulin as loading control in unstimulated WT MEFs and 
p53-/-crel-/-rela-/- MEFs reconstituted RelA-wt and empty pBABE-puro (EV). (B) Analysis of nuclear 
NFkB DNA-binding activity by Electrophoretic Mobility Shift Assay (EMSA) for kB DNA and NF-Y 
(loading control) probes of nuclear extracts prepared at indicated times after TNF stimulation from 
same cells as (B). (C) Scatter plots for all 113 identified genes with polyA+ RNA-seq showing 
their RPKM in log2 for each time point (0, 0.5hr, 1hr, and 3hr) in response to TNF between WT 
MEF cells and p53-/-crel-/-rela-/- MEF reconstituted with RelA-wt. R2 values of 0.69 to 0.83 are 
found across all time points and outliers were removed to produce the list of 104 target genes in 
subsequent analyses. (D) A map of the NFkB binding sites (kB DNA sequences) within each of 
the 234 RelA ChIP-seq peaks identified with an FDR <0.05 and associated with the 104 NFkB 
target genes. Full kB elements refer to 9, 10, and 11 bp sequences conforming to the consensus: 
5’-GGR(N3-5)YCC-3’, where R = A or G; Y = C or T; N = any nucleotide (A, C, G, or T). Half kB 
elements refer to 5’-GGR-3’ and 5’-YCC-3’.  (E) Correlation between RelA peak size and relative 
affinity of kB site sequence. Normalized counts of RelA ChIP-seq peaks retrieved from RelA ChIP-
seq data with RelA-wt expressing MEFs are plotted against PDBMA-determined z-scores of 
strongest kB binding site sequences for RelA:RelA, RelA:p50, and p50:p50 dimer retrieved 
from(Siggers et al., 2012). 
  

Figure S3. High affinity DNA binding by RelA is required for all TNF-induction of NFkB 
target genes, Related to Figure 3. (A) RelA DNA binding mutant shows normal interactions with 
p50, IkB⍺ and IkBβ as detected by RelA immunoprecipitation using WCE from unstimulated cells 
followed by immunoblotting for antibodies against RelA, IkBb, IkBa, and p105/p50. (B) Nuclear 
extracts (NE) and cytoplasmic extracts (CE) from TNF-stimulated MEFs were analyzed by 
immunoblotting for antibodies against RelA, IkBb, and IkBa, with p84 (nuclear loading control) 
and ⍺-Tubulin (cytoplasmic loading control). Quantified western blots for nuclear RelA, and 
cytoplasmic IkBb and IkBa protein expression are shown on the right. (C) Genome browser tracks 
of RelA binding events in reconstituted RelA-wt and RelADB cells for known NFkB target genes, 
Nfkbia and Cxcl10, in response to 0.5hr of TNF stimulation. Data is representative of two 
independent experiments. (D) Correlation between RelA peak dependence on RelA’s high DNA 
affinity and PBM-determined z-scores of strongest kB binding site sequences for RelA:RelA, 
RelA:p50, and p50:p50 dimers retrieved from (Siggers et al., 2012). Of the seven 10-bp kB site 
sequences within non-reduced RelA peaks, the five with the strongest z-scores were plotted. (E) 
Plots of polyA+RNA-seq data for Nfkbia and Cxcl10 genes shown in RPKM in response to TNF 
at indicated times in WT and RelADB-reconstituted in p53-/-crel-/-rela-/- MEFs. (F) PCA plot of the 
104 NFkB-dependent genes in response to TNF at indicated times using log2 of RPKM. (G) 
Genome browser tracks of RelA binding events for Rrad gene in reconstituted RelA-wt and RelADB 
mutant cells. 
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Figure S4
Figure S4. Generation of a RelA Transactivation Domain mutant knock-in mouse strain, 
Related to Figure 7.  (A) Schematic of the knockin strategy, first targeting the RelA gene with a 
mutant allele containing the CI mutation in TA2 and deletion of TA1, as well as a Neo gene that 
is flanked by FRT sites, then deleting Neo with FRT. (B) Photo of 12 day-old littermate mice of 
indicated genotypes (WT, RelATA/-, and RelATA/TA) prior to isolation of bone-marrow. (C) 
Confirmation of genotype. PCR product using primer set NDEL1B and NDEL2 with genomic DNA 
from tail DNA isolated from indicated pups was used to screen mice. PCR product for wild-type 
band showed at 273 bp, mutant band at 371 bp, visualized by 2% agarose gel. Genotyping results 
for mouse IDs corresponds to the mice in (B).   
 
  

Figure S5. Lack of RelA-TAD-dependence in the transcriptional response of MEFs to TNF 
or LPS is not due to cRel compensation, Related to Figure 2 and Figure 7. (A) RNA-seq 
analysis of 104 target genes, identified in Figure 2, from TNF or LPS stimulated MEFs or BMDMs 
in WT, RelATA/TA, crel-/-, and crel-/-RelATA/TA. Blue to red indicates low to high relative inducible 
expression. Asterisk marked next to BMDM data that are grayed out indicates genes that were 
not induced with the log2FC ³1 cut-off.  (B) polyA+RNA-seq heatmaps for the relative expression 
of 145 genes in crel-/- MEFs in response to TNF and LPS. Gene names and data plotted in 
heatmap are listed in Table S4. (C) Heatmap for RelA dependence of TNF- and LPS-induced 
genes in MEFs: percentage of peak expression in (Left panel)  RelATA/TA mutant vs. WT, and 
(Right panel)  crel-/-RelATA/TA mutant vs. crel-/-.  Blue to orange indicates low to high percentage of 
inducible expression relative to WT or crel-/- control and low to high percentage of inducible 
expression indicates high to low RelA TAD dependence. Genes were first clustered by TAD 
dependence or not in TNF response and re-arranged within each cluster by TAD dependence in 
LPS response. Gene names and data plotted in heatmap are listed in Table S4. Top results of 
transcription factor motif  enrichment analysis are shown for the gene groups by TNF- and LPS-
dependent, TNF-dependent and LPS-independent, and TNF- and LPS-independent. (D) 
Heatmap for RelA dependence of the 26 TAD-independent genes in TNF response, indicated in 
(C), in RelATA/TA MEFs and complemented p53-/-crel-/-rela-/- MEFs with empty pBABE vector (EV). 
Genes were re-arranged based on TAD dependence in TNF response.  
 
  

Figure S6. The RelA TA2 domain functions primarily via intrinsic affinity for CBP/p300, 
Related to Figure 5 and Discussion. (A) Schematic of the RelA variants involving mutation of 
the phosphorylation site S467 in murine RelA sequences. (B) Analysis of nuclear NFkB activity 
by EMSA of nuclear extracts prepared at indicated times after TNF stimulation of genetically 
complemented fibroblasts of indicated genotype. (C) Protein expression of RelA, IkBb, IkBa, and 
Actin in unstimulated cells as assayed by immunoblotting. (D) PCA plot of the transcriptional TNF 
response of all 104 NFkB target genes at indicated times and cell variants. (E) Heatmap of relative 
induced expression in response to TNF stimulation of the 104 target genes in same cell variants, 
as analyzed by polyA+RNA-seq. 
 
  

Figure S7. Synergistic TA1/TA2 activated genes require higher kB motif binding strength 
and more RNA Pol II binding to their promoters, Related to Figure 7. Comparison of GC 
content, kB motif binding strengths, and RNA Pol II recruitment  for top 25% genes based on their 
model kact values that are from either synergistic (11 genes) or redundant (12 genes) TA1/TA2 
activity. (A) Comparison of GC content from ±300 bp from gene TSS. (B) Comparison of kB motif 
binding strength (z-scores) derived for RelA:p50, RelA:RelA, and p50:p50 dimers retrieved from 
Siggers et al. 7 genes from each category with kB motif z-scores are shown. No significant p-
values were determined with kB motif binding strength in z-scores between the two categories. 
(C) Comparison of RNA Pol II ChIP-seq normalized reads for -100 bp to 50 bp from each gene 
TSS. N.S., not significant. p-values were determined by Mann-Whitney U-test. 
 
 
